Fractyl Health, Inc. (GUTS)
4.42
+0.19
(+4.49%)
USD |
NASDAQ |
Oct 09, 15:04
Fractyl Health Debt to Equity Ratio : -36.48 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -36.48 |
| March 31, 2026 | 2.845 |
| December 31, 2025 | 6.518 |
| September 30, 2025 | -19.57 |
| June 30, 2025 | -3.389 |
| March 31, 2025 | 9.635 |
| December 31, 2024 | 2.199 |
| September 30, 2024 | 1.251 |
| June 30, 2024 | 0.8653 |
| March 31, 2024 | 0.7191 |
| Date | Value |
|---|---|
| December 31, 2023 | -1.150 |
| September 30, 2023 | -1.116 |
| June 30, 2023 | -1.110 |
| March 31, 2023 | |
| December 31, 2022 | -1.216 |
| September 30, 2022 | |
| December 31, 2021 | -1.454 |
| September 30, 2021 | -1.543 |
| December 31, 2020 | -1.174 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Co-Diagnostics, Inc. | 0.1415 |
| Spectral AI, Inc. | -1.349 |
| Vaxcyte, Inc. | 0.0419 |
| Moderna, Inc. | 0.1904 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 81.98M |
| Total Liabilities (Quarterly) | 83.64M |
| Shareholders Equity (Quarterly) | -1.665M |
| Current Ratio | 3.152 |
| Net Debt Paydown Yield | 0.11% |